Faster diagnosis of CNS disorders

A breakthrough for the fast and objective measurement of brain function

One in four people will suffer from a serious brain disorder such as Alzheimer’s, Parkinson’s, depression, bipolar disorder or schizophrenia.

Yet, unlike other physical conditions, there is up till now no low-cost, non-invasive, convenient and objective way of measuring brain function that facilitates the fast and accurate diagnosis of brain and nervous system disorders. It can take 12 years to diagnose a mental illness such as bipolar disorder and Alzheimer’s can only be definitively diagnosed after death.

Delays like these create suffering for patients and their families as they wait for a diagnosis. At the same time, they lose the advantages of early treatment. Delays also frustrate clinicians and significantly contribute to the $2 trillion dollars per year spent on managing the impact of brain disorders.

EVestG™ is a unique proprietry technology that sensitively measures neural and brain function via a new window into the brain. EVestG™ promises to be able to objectively diagnose a broad range of neurological and psychiatric disorders to an accuracy greater than 90% on measurement. When successfully commercialised, it will provide the world’s clinicians with the first ever quick, painless, low-cost and objective diagnostic tool.

Patients, clinicians and government are demanding better treatment and management options. EVestG™ will introduce a paradigm shift in the care of mental illness and neurological disease.

Contact us for more information about our business or the technology and its applications.